CIK 0001658551 · Non-accelerated filer<br>Smaller reporting company
Amylyx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMLX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464600503
- Phone
- 617-682-0917
- Business address
- 55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Co-Chief Executive Officer acquired 63,694 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Gift Chief Financial Officer gave 11,072 shares (gift)
- 8-K Event Other events
- SC 13D/A Stake Beneficial Ownership Report
- 4 Option exercise Chief Financial Officer acquired 18,165 shares (option exercise)
- 4 Gift 10% owner gave 2,000,000 shares (gift)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Planned sale Chief Legal Officer sold 6,164 shares at $20.88 ($128,686)
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Option exercise Chief Commercial Officer acquired 20,000 shares (option exercise)
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 14 of 23 · 446 filings